Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Certain drugs change freshwater snail shells to a "banana" shape.

Ageratum conyzoides L. extract may effectively and safely treat hair loss.

Certain genetic markers may increase or decrease prostate cancer risk.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Finasteride and tamsulosin hydrochloride can be safely taken together without significant interaction.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

% free PSA and urinary markers help better identify prostate cancer.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Nutritional interventions can help restore balance in male health by targeting oxidative stress and hormonal issues.

Finasteride may help prevent prostate cancer.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.